REQUEST FOR THE PROPOSAL No. 19/2021-ARG – Phase I, First-in-Human type, clinical trial – update of 26.07.2021
The order is carried out as a part of the project titled:
– ARG: „PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-415/17)
co-financed by the European Union Funds and carried out on the basis of the competitiveness principle
We hereby look for Contractor ready to perform:
Organization and comprehensive execution of the phase I, First-in-Human type, clinical trial for a OATD-02 compound
On 30/06/2021, the Ordering Party has updated Załącznik 1 in the PL version (Appendix 1) by adding dotted places for subtotals in the table and has updated Załączniki 1-2 in the ENG version (Appendices 1-2) by adding dotted places for subtotals in the table, as well as correcting the translations (changes in translations are marked in green). The deadline for submitting offers remains unchanged.
Below, the Ordering Party provides answers to questions that have arisen up to the set deadline. Answers to questions provided by the Ordering Party constitute an integral part of the documentation concerning the tender procedure. The deadline for submitting offers has been extended to August 4, 2021, 23:59. The change of date is marked in red in the proposal.